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ReseaRch aRticle
the use of a thyroid shield for intraoral anterior oblique occlusal 
views—a risk-based approach
1Mark Worrall, 2Alison Menhinick and 3Donald J Thomson
1Department of Medical Physics, Ninewells Hospital and Medical School, Dundee, UK; 2Department of Radiology, Dundee Dental 
Hospital, Dundee, UK; 3Department of Dental Radiology, Edinburgh Dental Institute, Edinburgh, UK
Objectives: To estimate the radiation dose reduction to the thyroid for an anterior oblique 
occlusal view from the use of a thyroid shield, compare this with the variation in thyroid dose 
resulting from differences in examination positioning and discuss the additional considera-
tions associated with the use of a thyroid shield before making a recommendation on their 
routine use for this examination.
Methods: Doses to the oral mucosa, the salivary glands, the thyroid, the extrathoracic 
airways, the oesophagus and the lungs were directly measured for anterior oblique occlusal 
X-rays of a Rando phantom with and without a thyroid shield using strips of calibrated 
XRQA Gafchromic film. The examination was also simulated using Monte Carlo software for 
the without thyroid shield case for a comparison of the dose and to evaluate the dosimetric 
effect of suboptimal examination positioning.
Results: A 36% reduction in thyroid dose was measured as a result of thyroid shield use; the 
effective dose reduction is of the order of 22%. Suboptimal positioning was found to increase 
thyroid dose by a far more significant amount.
conclusions: Despite the reduction in thyroid dose, cost-benefit considerations mean that 
the purchase of a thyroid shield is only recommended where a very high number of anterior 
oblique occlusal views are undertaken. Optimization efforts for this examination are better 
focussed on training in examination positioning.
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introduction
In UK, the Ionising Radiations (Medical Exposure) 
Regulations 20001 require that patient doses resulting 
from radiodiagnostic examinations be “as low as reason-
ably practicable consistent with the intended purpose”. 
This requires each examination to be optimized, which 
includes considerations relating to the choice of X-ray 
generating equipment, detector, exposure factors, beam 
and patient positioning and patient shielding. The as 
low as reasonably practicable principle comes from the 
recommendations of the International Commission on 
Radiological Protection (ICRP)2 as it is synonymous 
with their “as low as reasonably achievable” (ALARA) 
principle. The ICRP intend that ALARA have “social 
and economical factors taken into account”. Hence, 
when considering optimization locally, financial consid-
erations along with an assessment of any potential 
non-radiation risk introduced by any of the measures 
intended to reduce patient exposure should be included.
For intraoral examinations, opinion is divided on 
whether or not to provide the patient with a thyroid 
shield. Some formal guidance states that best practice is 
to give the patient a thyroid shield wherever possible.3–5 
Other guidance states that the provision of thyroid 
protection is likely to only be of use for those views 
where the thyroid could be in the primary beam.6–10 The 
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latter state that the decision should involve consultation 
with the local medical physics expert or equivalent.
The medical physics expert will give their advice 
based in part on their understanding of the reduction 
in absorbed dose to the thyroid as a result of using a 
thyroid shield. Many studies have tried to quantify this; 
Sikorski and Taylor11 for a full mouth intraoral series, 
Schmidt et al12 for a periapical and Hoogeveen et al13 
for upper anterior views. Both Sikorski and Taylor11 and 
Hoogeveen et al13 suggested that thyroid shields should 
be used for the views they studied whilst Schmidt et al12 
suggested that thyroid shields were  not a reasonable 
measure for the views they studied. The authors cannot 
find any study that has explicitly investigated an ante-
rior oblique occlusal view (also known as a standard 
occlusal view), although, Hoogeveen et al13 did suggest 
that since their results indicated the use of a thyroid 
shield for upper anterior views this would be equally 
true of occlusal views. Whaites and Drage14 recom-
mend that a thyroid shield be used for anterior oblique 
occlusal views.
It is the author’s intention in this work to estimate 
the dose saving to the thyroid for an anterior oblique 
occlusal view as a direct result of the use of a thyroid 
shield, to compare this with the variation in thyroid dose 
resulting from differences in examination positioning, to 
consider economic factors and to discuss the additional 
considerations associated with the use of a thyroid shield 
before making a recommendation on whether or not 
thyroid shields should be used routinely for this view.
Methods and materials
Choice of phantom
The head, neck and chest of an Alderson Rando 
anthropomorphic phantom (The Phantom Laboratory, 
Salem, NY) were used for all of the measurements in 
this work. The Rando phantom is made of tissue equiv-
alent materials that follow the International Commis-
sion on Radiation Units report 4415 and is constructed 
in slices so as to allow for the placement of thermo 
luminescent detectors (TLDs) within. Whilst Rando is 
made of tissue equivalent materials, any measurement 
made within the Rando phantom is not going to be the 
same as that in an equivalent position in a patient. This 
is owing to anatomical differences between Rando and 
a patient; of most relevance to dental work, Rando does 
not have an oral cavity. Given this, it would be expected 
that there will be more attenuation of the radiation 
from an anterior oblique occlusal view near the point of 
radiation entering the body with Rando than for a real 
patient.16 Conversely, the fact that no image receptor 
can be placed inside the phantom will mean that there is 
more transmission than would be expected for a patient 
during a real examination.
Nevertheless, in an assessment of whether or not a 
thyroid shield reduces the dose to the patient’s thyroid 
during an anterior oblique occlusal examination, this 
does not matter. As long as the same phantom is used 
in both cases, with the same X-ray beam and radiation 
detector positioning, the difference in results between 
the with and without thyroid shield cases will be accu-
rate, even if  the estimation of the absolute thyroid dose 
is inaccurate.
Choice of detector
Previous work in quantifying the reduction in the 
absorbed dose to the thyroid with thyroid shields has 
used TLDs,12 film11 and a Raysafe Xi survey detector.13
The small size of TLDs means that the measured 
dose only reflects that over a very localized area. To 
build up an idea of the dose distribution throughout the 
phantom, lots of TLDs are required allowing values of 
dose at any point to be interpolated from the measured 
values. However, accurate sampling of the distribu-
tion in this case would require TLD placement that is 
much closer together than the predrilled holes of Rando 
allows for.
The RaySafe Xi survey detector (RaySafe AB, 
Billdal, Sweden) has a significant energy dependence. 
The use of  the detector in a different beam quality from 
that in which it was calibrated requires that a correc-
tion factor, kQ, be applied to account for the differences 
in detector response in the calibration and use condi-
tions.17 In normal use with dosemeters, it is not common 
practice to apply kQ as it is generally very close to unity. 
The energy dependence of  the detector, and Hoogeveen 
et al’s13 unusual use of  the detector, are such that this is 
not the case. Local measurements made with RaySafe 
Xi survey and R/F detectors demonstrated that whilst 
the two agreed to within ±3.5% in a free in air geom-
etry, the survey detector measured 21% higher than 
the R/F detector when the two were placed between 
two 5-cm blocks of  Solid Water HE (Gammex, A Sun 
Nuclear Company, FL). The R/F detector is known to 
have less energy dependence than the survey detector, 
and theoretical calculations of  the expected attenua-
tion from the Solid Water agree closely with the result 
measured by the R/F detector. It is concluded that for 
the beam quality used in the work of  Hoogeveen et al13 
the value of  kQ that should have been applied to the 
result from the survey detector is likely to have been 
close to 0.82. It is acknowledged that this has no effect 
on their calculation of  the dose reduction from the use 
of  a thyroid shield but it does affect their estimation of 
absolute dose.
The detector used throughout this work is XRQA 2 
Gafchromic film (Ashland, Ashland Global Holdings 
Inc., Covington, KY). This radiochromic film is self-de-
veloping upon irradiation in a manner that is propor-
tional to the quantity of radiation used to expose it. 
Therefore, it can be used for making dosimetric measure-
ments. It is sold in sheets that are 25 × 30 cm in size 
but can be cut to any smaller shape without affecting 
its performance. Where large strips of Gafchromic film 
were placed in between slices of the Rando phantom, a 
birpublications.org/dmfr
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dose distribution over the whole area can be determined 
from a single film.
Gafchromic film has been widely used throughout 
diagnostic radiology and interventional radiology 
for everything from quality control measurements to 
quantifying patient entrance skin dose.18–22 It has also 
been used for dose measurements in intraoral radiog-
raphy.23,24 Such widespread use means that the optimal 
technique for using the film has been determined and 
shared. The optimal use of the film requires it to be 
given enough time to fully develop post-exposure, to be 
stored correctly pre- and post-exposure, to be exposed 
to a minimum dose in order to exhibit a stable response 
to exposure and to be digitized in a specific way to be 
useful for dose estimation. All of the recommendations 
made elsewhere with regards to the optimal use of the 
film25 were adhered to throughout this work.
Intraoral X-ray unit
All X-ray exposures in this work were undertaken on 
a Sirona Heliodent DS intraoral X-ray unit with fixed 
60  kV, 7  mA and variable time. The half  value layer 
(HVL) of the unit was measured to be 1.94 mm of 
Aluminium at 60 kV and stated as 1.9 mm of Aluminium 
by the manufacturer. It was installed in 1998, has been 
in routine clinical use ever since and is subject to bien-
nial testing by NHS Tayside’s Radiation Physics depart-
ment and more frequent quality assurance (QA) testing 
by local users. At the time of this work, the unit’s testing 
was up to date and it was performing within the manu-
facturer’s specifications.
Gafchromic film calibration
An estimation of dose from the response of the 
Gafchromic film to radiation exposure is only possible 
with an accurate calibration. Gafchromic film exhibits 
a variable response to exposures made at different 
kVps and of varying beam qualities (defined by their 
HVL). Therefore, the calibration needs to mimic the 
exposure conditions of the phantom exposures as 
closely as possible to be accurate. The aim was to cali-
brate the Gafchromic film over a dose range of 0.5 to 
5 mGy as this would cover the full range of measure-
ments made throughout the phantom work. The XR 
QA 2 Gafchromic film is stated by the manufacturer 
as having a useful range of 1–200 mGy, although, the 
film has been found to have a useful range beginning at 
0.5 mGy locally.
A RaySafe R/F detector was placed between two 
5-cm blocks of Solid Water HE and an exposure made 
at 0.5  s. Three measurements were taken to ensure 
there was excellent repeatability between exposures. 
Each single exposure was less than 0.5 mGy; in order 
to achieve doses in the range of 0.5–5 mGy it is neces-
sary to irradiate each piece of Gafchromic film multiple 
times.
A sheet of  Gafchromic film was divided into 10 
squares, each of  which was placed in turn between 
two 5-cm blocks of  Solid Water HE. Each square of 
film was irradiated in turn at 0.5 s, the predetermined 
number of  times to achieve a known and incremen-
tally increasing dose between 0.5 and 5 mGy. In total, 
10 calibration films were irradiated at approximately 
0.5 mGy intervals.
The films were given enough time to fully develop (a 
minimum of 48 h) and then digitized using an EPSON 
reflective scanner—in keeping with optimal use of 
Gafchromic film, only the red channel of the scanned 
images was used and all scanner suggested image correc-
tions were disabled.
Once digitized, measurements of the digital 
Gafchromic film images were made using the ImageJ 
software package US National Institutes of Health, 
Bethesda, MD).26 A ROI was drawn on each film and the 
average pixel value recorded—the calibration of the film 
was created using the relationship between measured 
pixel values and measured exposure. The calibration 
curve was determined using MATLAB’s (MathWorks, 
Natick, MA) cftool curve fitting toolbox.27
Finally, a correction was required to the measured 
kerma to account for backscatter. The Raysafe R/F 
detector is lead backed, therefore, does not measure back-
scattered radiation, but the Gafchromic film does. The 
increase in kerma as a result of backscatter was measured 
using a Radcal 6 cc ionization chamber (Radcal Corpora-
tion, Monrovia, CA) placed free in a free in air geometry 
and then on top of 5 cm of Solid Water HE. Both expo-
sures were made at 60 kVp, at the same focus to detector 
distance and with the same exposure time. The difference 
in these measurements of kerma can be attributed to back-
scatter. It is worth noting here that the ionization chamber 
could not have been used for all of the calibration expo-
sures because it would have required the application of an 
unknown, but likely significant, kQ factor.
Exposures of Rando
Five large strips of Gafchromic film were placed 
in between adjacent slices of Rando that corresponded 
to just below the mouth, the salivary glands, the top of 
the thyroid, the base of the thyroid and the apex of the 
lungs, as can be seen in Figure 1.
The intraoral X-ray set described in  “Intraoral X-ray 
unit” was used for all of the exposures. The rectangular 
cone of the intraoral unit was positioned for an ante-
rior oblique occlusal by a superintendent dental radiog-
rapher with 33 years of experience, as per Figure 2. A 
tilt angle of 65° was used, in line with best practice.14 
Markers were placed on the top of Rando’s head to 
aid with precise reproducibility of cone position for 
the with and without thyroid shield cases, since it was 
necessary to take Rando apart in-between to replace the 
Gafchromic film strips.
The exposure factors used clinically on this unit for 
an anterior oblique occlusal view (60  kV, 7  mA, 0.5 s 
producing a measured entrance dose without backscatter 
of 1.35 mGy) were used to perform the examination 
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Figure 1  The XRQA Gafchromic film positioned within the Rando 
phantom.
Figure 2  The intraoral X-ray tube positioned for the anterior 
oblique occlusal view.
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on Rando. The examination was performed 30 times 
consecutively—this was necessary to increase the expo-
sure of the Gafchromic film to above the minimum 
threshold of its stable range and into the range that had 
been calibrated earlier.
Once 30 exposures had been performed, the 
Gafchromic films were replaced with fresh strips—it 
was necessary to tightly trim these to the contours of 
the Rando phantom so that the thyroid shield was not 
pushed to an unnatural position when it was placed 
around Rando. The thyroid shield was of 0.35 mm lead 
equivalence. The cone of the intraoral unit was posi-
tioned as before using the markers previously placed on 
top of Rando’s head to ensure reproducibility. A further 
30 exposures were made.
Analysis of irradiated Gafchromic film for thyroid dose 
assessment
The irradiated films were allowed to fully develop and 
then digitized using the same process as for the calibra-
tion films.
Once digitized, the images were imported into 
ImageJ. A line profile was drawn on each film extending 
from the front to the back along the central axis of the 
X-ray beam (i.e. the plane of highest radiation dose) to 
examine the variability with depth. Using an ImageJ 
contour plotter plugin28 contours were drawn on the 
image that correspond to levels of equivalent exposure. 
This gives a visual representation of the dose distribu-
tion throughout each film along both axes. This image 
also indicated the most uniform area to make an average 
measurement of pixel value in an area equivalent to 
the thyroid using a ROI drawn by the user. These were 
generally placed in an area that corresponded to 2 cm 
into the Rando phantom.
The average pixel value for any ROI that corre-
sponds to the location of an organ can be used with the 
Gafchromic film calibration to produce a result for the 
measured absorbed dose to that organ. The absorbed 
dose to the thyroid, in µGy, was estimated by taking 
the average pixel value in a region that corresponds 
to the estimated position of the thyroid and using the 
Gafchromic film calibration. 
Software estimation of the absorbed dose to the thyroid 
and effective doses
PCXMX29 (STUK - Radiation and Nuclear Safety 
Authority, Helsinki, Finland) is a Monte Carlo program 
for calculating patient organ and effective doses in radio-
graphic X-ray examinations. The anatomical data for the 
program come from the mathematical adult hermaphro-
dite phantom models of Cristy and Eckerman30 which 
are slightly amended for more realistic external exposure 
conditions. Full control is given over the external X-ray 
beam; everything from size, position, angulation and 
beam quality (kVp, beam filtration and anode angle). It 
is not possible to add additional features however; there-
fore, only the anterior oblique occlusal views without 
the thyroid collar could be simulated.
An anterior oblique occlusal view that was equivalent 
to that performed on the Rando phantom was simulated 
in PCXMC using 60  kVp, a filtration of 2.03 mm Al 
(calculated using a measured HVL of 1.94 mm Al and 
an assumed anode angle of 12°). An air kerma of 1.35 
mGy (that measured for the intraoral unit using expo-
sure factors of 60 kVp, 7 mA and 0.5 s) was used. The 
geometry was as shown in Figure 3, a screenshot from 
the PCXMC program. This was deemed to be as close 
to the exposure undertaken on the Rando phantom as 
possible. The program returned organ doses for all of 
the organs contained in the phantom and an effective 
dose.
Variations were made to the simulation to determine 
the effect they would have on the patient’s organ and 
birpublications.org/dmfr
Figure 3 . The geometry of the anterior oblique occlusal view in the 
PCXMC program.
Figure 4  The geometry of an anterior oblique occlusal view with 
poor height centring in PCXMC.
Figure 5  The geometry of an anterior oblique occlusal view with 
poor cranial caudal angulation in PCXMC.
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effective doses. These changes were intended to repre-
sent variances in positioning practice that could be 
observed in the dental surgery.
Changes were made to the z-axis centring; the first 
exposure was deemed to be optimally centred, subse-
quent exposures moved the centre downwards in 1 cm 
increments from 1 to 5 cm. This was deemed to cover 
all realistic cases of slightly suboptimal positioning to 
very poor positioning, with the worst case illustrated in 
Figure 4. In this case, the whole of the thyroid is clearly 
in the path of the primary beam.
Variations were made of the cranial caudal angle; the 
first exposure had an angle of 65° and was deemed to 
be optimal. Further exposures varied the angle between 
55° and 75° in 5° increments. This was deemed to cover 
all realistic cases of slightly suboptimal positioning 
to poor positioning, with the worst case illustrated in 
Figure 5. In this case, the whole of the thyroid is clearly 
in the path of the primary beam.
Finally, some variations were combined in order to 
find the worst case effect on patient organ and effective 
doses. These included combinations of a reduction in 
centring height by 5 cm and a cranial caudal angle of 
60° and then 55°.
As with the Gafchromic film exposures with Rando, 
it should be noted that these simulations did not include 
an image receptor. Therefore, the calculated dose to all 
organs can be regarded as an absolute worst case.
Estimates of effective dose using measured doses
The ICRP define effective dose as the sum of all indi-
vidual organ absorbed doses multiplied by a radiation 
weighting factor (which is unity for X-rays) and a tissue 
weighting factor.2 To estimate the effective dose for the 
anterior oblique occlusal examinations undertaken with 
and without the thyroid shield, absorbed doses were 
estimated for the oral mucosa, the salivary glands, the 
thyroid, both extrathoracic airways, the oesophagus and 
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the lungs using ROIs on the Gafchromic films that corre-
sponded to the approximate position of each organ.
The absorbed dose to all other organs in the body 
(which were not measured using Gafchromic film), were 
calculated using the PCXMC program and were taken 
to be the same for the with and without thyroid shield 
exposure. This is a valid assumption, since internal 
scatter does not reach much beyond the range of organs 
under consideration in this work and external scatter is 
much reduced outside the same range.
With an estimate for absorbed dose—obtained from 
measurement for the exposed organs and simulated for 
the organs that received little or no exposure—for all of 
the organs used by the ICRP in their definition of effec-
tive dose now available, the relevant tissue weighting 
factors were applied and an effective dose for the with 
and without thyroid shield cases calculated, in µSv.
Results
Gafchromic film calibration
Despite working at and just above the minimum 
threshold for stable film response to radiation, a good 
exponential fit for film calibration was achieved, with 
an R2 of 0.969 reported by MATLAB. Whilst it has 
been demonstrated possible to achieve an R2 of greater 
than 0.99 when working comfortably within the film’s 
operational range (i.e. tens of mGy),31 the calibration 
obtained for this work covered the full range of expo-
sures encountered within the film irradiated in Rando. 
Since no extrapolation of the calibration was required, 
the uncertainty of results derived using the calibration 
is reduced.
Rando Gafchromic film exposures
An assessment of dose with depth: Figure 6(a-e) shows 
the change in dose with anteroposterior depth where 
zero is the phantom entrance for the Gafchromic film 
positioned (a) just below the mouth, (b) the salivary 
glands, (c) the top of the thyroid, (d) the base of the 
thyroid and (e) the apex of the lungs corresponding to 
the visible film strips in Figure 1. The black line repre-
sents the dose without a thyroid shield, the red line 
represents the dose with the thyroid shield. Figure  6f 
is a lateral view of the Rando phantom; the horizontal 
lines represent the locations at which the Gafchromic 
film was placed. The topmost four vertical lines indicate 
a depth of 60 mm into the phantom from the entrance 
surface to help the reader visualize the dose distributions 
shown in Figure 6a–d within the phantom; the bottom-
most vertical line indicates a depth of 40 mm into the 
phantom from the entrance surface to compare with the 
dose distribution shown in Figure 6e.
The thyroid shield does not cover the mouth, therefore, 
the with and without thyroid shield exposures should 
be very close. Figure 6(a) demonstrates that this is the 
case. A peak dose of 28–35 µGy can be seen at the skin; 
this decreases moving into the phantom and flattens 
out around 12 µGy at a depth of 4–6 cm. A large ROI 
(centred on the central axis but extending equally to both 
right and left) placed at a 2-cm depth records an average 
dose of 12.48 and 12.54 µGy for the with and without 
thyroid shield exposures. This level of agreement gives 
confidence that the exposure levels experienced by the 
phantom with and without the thyroid shield were very 
similar and that the measures taken to ensure accurate 
repositioning were effective.
A properly worn thyroid shield would be expected 
to reduce the dose to the salivary glands partially by 
direct protection but predominantly by way of reducing 
the amount of radiation in the area below that could 
scatter upwards. This is demonstrated to be the case in 
Figure 6(b). At a superficial depth, the trend in increasing 
dose is the same for both exposures but the dose level is 
almost half  with the thyroid shield in place. This is the 
contribution of direct protection from incident radia-
tion. With increased depth, the dose without the thyroid 
shield is observed to continue increasing—this is a result 
of direct irradiation combining with internal scatter 
from above and below. The thyroid shield removes 
some of the incident radiation at and below the salivary 
glands thereby reducing the internal scatter. Therefore, 
the dose is observed to steadily decrease with depth. A 
large ROI (centred on the central axis but extending 
equally to both right and left) placed at a 2cm depth 
records an average dose of 13.7 and 18.2 µGy for the 
with and without thyroid shield exposures
The dose at the top of the thyroid follows a similar 
pattern to that at the salivary glands. At a superficial 
depth, the trend in increasing dose is the same for both 
exposures but the dose level is around two-thirds with 
the thyroid shield in place. This is the contribution of 
direct protection from incident radiation. With increased 
depth, the dose without the thyroid shield is observed 
to continue increasing—this is a result of direct irradi-
ation combining with internal scatter from above and 
below. The thyroid shield removes some of the incident 
radiation at and below the top of the thyroid thereby 
reducing the internal scatter, hence the dose steadily 
decreases with increasing depth. A large ROI (centred 
on the central axis but extending equally to both right 
and left) placed at a 2-cm depth records an average dose 
of 9.7 and 15.2 µGy for the with and without thyroid 
shield exposures.
The dose at the base of the thyroid follows the 
same trend at superficial depths; there is an increase 
in dose for both exposures but the dose with the 
thyroid shield is around half  of that without the 
thyroid shield. The peak dose is reached at a depth of 
around 8–10 mm which is more superficial than for 
the organs considered so far. This is because the base 
of the thyroid is sufficiently far away from where the 
primary beam first enters the patient that there is less 
radiation reaching this far down at a depth greater 
than 10 mm. The peak around 8–10 mm is the result 
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Figure 6  Dose with increasing anteroposterior depth of phantom at (a) just below the mouth, (b) the salivary glands, (c) the top of the thyroid, 
(d) the base of the thyroid and (e) the apex of the lungs. The exposure without the thyroid shield is shown in black, the exposure with is shown 
in red (f) a lateral view of the phantom; horizontal lines indicate the position of the Gafchromic film. The topmost four vertical lines indicate a 
60 mm depth from the entrance surface of the phantom, the bottommost line indicates a 40 mm depth.
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of some primary radiation and scatter from above and 
below. With the thyroid shield the peak is also around 
8–10 mm depth, but around two-thirds the dose. The 
dose then remains steady moving deeper into the 
phantom, the result of scatter from above and below. 
A large ROI (centred on the central axis but extending 
equally to both right and left) placed at a 2cm depth 
records an average dose of 10.5 and 16.2 µGy for the 
with and without thyroid shield exposures.
At the apex of the lungs, the trends are similar to 
those at the base of the thyroid. The peak dose is reached 
at a depth of around 8–10 mm and the dose with the 
thyroid shield is around two-thirds of the dose without. 
The dose without the thyroid shield is then observed to 
decrease moving deeper into the phantom because the 
 birpublications.org/dmfr
Figure 7  (a) The dose distribution at the base of the thyroid where 
no thyroid shield is worn and (b) with a thyroid shield. Radiation is 
incident from the top of the film at the centre. Dose levels are included 
in the key next to the image.
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apex of the lungs is far from where the radiation first 
enters the patient so there is not as much reaching this 
far down at depths of greater than 10 mm. The peak is 
the result of some primary radiation and scatter from 
above and below. With the thyroid shield the peak is 
around 13 mm depth and around two-thirds the dose 
level. The dose remains steady moving deeper into the 
phantom, the result of scatter from above and below. 
A large ROI (centred on the central axis but extending 
equally to both right and left) placed at a 2cm depth 
records an average dose of 10 and 13.7 µGy for the with 
and without thyroid shield exposures.
An assessment of thyroid dose: Assessing the absorbed 
dose to the thyroid requires an examination of the 
three  dimensional dose distribution across the whole 
organ, which is expected to vary such that it will decrease 
towards the posterior and the base of the gland. Using 
the Gafchromic film exposed at the base of the thyroid 
it is confirmed that this is the case in the anteroposte-
rior plane, as can be seen in Figure  7 which contains 
isodoses created from the digitized films base without 
(a) and with (b) the thyroid shield. Note that, although, 
the colours remain constant, the scale changes between 
(a) and (b). The brown colour in Figure  7(a) is the 
Gafchromic film that extended in front of the phantom 
during the examination.
With the data that has been presented it is not possible 
to determine the absorbed dose accurately, although, 
an estimate of the dose reduction as a result of the 
thyroid shield is possible. Entrance skin dose reductions 
of the order of 38–50% were discussed in “An assess-
ment of dose with depth”, however, the thyroid is not 
positioned so superficially. Looking at the differences 
in dose measured using the ROI placed at a depth of 2 
cm gives a reduction of 36.2% at the top of the thyroid 
and 35.2% at the base. These reductions are consistent 
enough to make their average, 35.7%, a reasonable repre-
sentation of the absorbed dose reduction to the thyroid 
arising from the use of a 0.35 mm lead equivalent 
thyroid shield.
Effective dose assessment: By assigning one or more 
organs from those used by the ICRP in their calcula-
tion of effective dose2 to each piece of Gafchromic film 
and using the dose results reported in “An assessment 
of dose with depth”, it is possible to estimate an effec-
tive dose for the exposure with and without the thyroid 
shield in order to estimate the extent of the reduction in 
effective dose as a result of the thyroid shield.
The organs used for this calculation were the oral 
mucosa, the salivary glands, the thyroid, both the extra-
thoracic airways, the oesophagus and the lungs.
The absorbed dose to all other organs were calcu-
lated using the PCXMC program and were taken to be 
the same for the with and without thyroid shield expo-
sure. This is a valid assumption, since internal scatter 
does not reach much beyond the range of organs under 
consideration in this work and external scatter is much 
reduced outside the same range.
The effective dose without the thyroid shield was 
calculated to be 7.0 µSv. With the thyroid shield, this 
reduced to 5.5 µSv. This represents a per examination 
effective dose reduction of 1.5 µSv—a reduction of 
21.5%.
PCXMC estimated an effective dose of 8.4 µSv for 
a simulation equivalent to the without thyroid shield 
exposure. The difference between the simulated and 
calculated from measured organ doses effective doses 
is predominantly owing to the difference in dose to the 
oral mucosa; PCXMC estimated this as far higher than 
measured in Rando – this is to be expected since the 
mathematical phantom has an oral cavity whilst Rando 
attenuates much of the radiation in this area before it 
is measured. The measured and simulated doses to the 
thyroid were 15.7 and 7.2 µGy, respectively.
PCXMC simulations
For the simulation that best matched the work performed 
with Rando, the absorbed dose to the thyroid was calcu-
lated to be 7.2 µGy.
The lowering of the centre point of the X-ray beam 
in 1 cm increments up to 5 cm was found to significantly 
increase the dose to the thyroid, as would be expected 
given the thyroid is increasingly in the primary beam 
with each increment. Increases in absorbed dose to the 
thyroid were of the order of 41, 61, 105, 167 and 196% 
with each increment; as such, the absorbed dose to the 
thyroid becomes significantly increased with very poor 
positioning, although, even a slightly lower centre point 
position increases the absorbed dose to the thyroid by 
almost half. The effective dose is calculated to increase 
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with the absorbed dose to the thyroid, although, that 
increase is less at the 5 cm lower than optimal position 
than for the 4 cm position. This is owing to reduced 
absorbed dose to the brain, oral mucosa and salivary 
glands with less of an increase in the absorbed dose to 
the thyroid.
Changing the cranial caudal angle of the X-ray beam 
had a variable effect on absorbed dose to the thyroid and 
effective dose. At a 55° angle, there was a 5% reduction 
in absorbed dose to the thyroid because the angulation 
meant that less of the thyroid was in the primary beam. 
However, the effective dose increased by 17% owing to 
an increased dose to organs including the extrathoracic 
airways, the lymph nodes, the oral mucosa and the sali-
vary glands. At a 60° angle there is a 41% increase in 
absorbed dose to the thyroid because more of the organ 
is in the primary beam. The effective dose increases by 
21% as a result of the increased absorbed dose to the 
thyroid.
At a 70° angle, the absorbed dose to the thyroid 
reduces by 36% because less of the thyroid is in the 
primary beam. The effective dose reduces by 20% as a 
result of the reduced absorbed dose to the thyroid. At 
a 75° angle, these reductions are more so, with a 57% 
reduction in absorbed dose to the thyroid and a 38% 
reduction in effective dose.
So far each variation has been considered in isola-
tion. As a measure of a worst case increase in absorbed 
dose to the thyroid, the combination of a poorly centred 
X-ray beam (5 cm lower than optimal) and a suboptimal 
cranial caudal angle (60°) was simulated.
The absorbed dose to the thyroid was calculated to 
increase by 667% to 48 µGy whilst the effective dose 
increased by 223% to 18.7 µSv.
Discussion
The thyroid dose from a well-executed anterior oblique 
occlusal is estimated as 15.7 µGy, with an associated 
effective dose of 7.0 µSv. There is no comparative litera-
ture for this view, although, this dose falls well within the 
wide range of thyroid doses found in the literature in the 
review paper by Holroyd32 for intraoral examinations. 
There is also broad agreement with the simulations run 
in PCXMC, where the thyroid dose was 7.2 µGy and the 
effective dose was 8.4 µSv.
The use of a 0.35 mm lead equivalent thyroid shield 
led to a reduction in dose to the thyroid of 35.7% to 
10.3 µGy and a reduction in effective dose of 21.5% to 
5.5 µSv for this view.
As there was no image receptor used in this work, 
these doses can be presented as worst case since there 
was far more transmission of the primary beam than 
would be the case in a clinical examination.
The simulated exercise on the effect of suboptimal 
positioning demonstrated that lowering the centre of the 
X-ray tube by 1 cm increases the thyroid dose by 41%. 
The increase in thyroid dose is significantly worse the 
lower the X-ray tube centring, rising to a 196% increase 
at 5 cm lower than optimal. Reducing the cranial caudal 
angle by just 5° to 60° leads to a 41% increase in thyroid 
dose. The combination of reduced angulation and lower 
centring was found to lead to an enormous increase in 
thyroid dose.
The increase in thyroid dose for even the smallest 
changes to centring or angulation is higher than the 
magnitude of the reduction with the use of the thyroid 
shield. This implies there are greater gains to be made 
in thyroid dose reduction with training and audit 
on optimal positioning than simply with the use of a 
thyroid shield alone. Even where a thyroid shield is used, 
in cases of suboptimal positioning its performance is 
unlikely to match the level reported in this work because 
it will be less effective in shielding against the higher 
average energy of the poorly aligned X-ray beam.
The ICRP’s definition of ALARA includes “social 
and economical factors taken into account”; therefore, 
it is appropriate that there be a financial consideration 
when deciding upon whether or not to use a thyroid 
shield.32 The man-Sievert is a monetary value placed 
upon saving a population dose of 1 Sv and is a concept 
that is widely used for the protection of staff. Some 
countries choose to adopt several values, each refer-
ring to a specific level of dose, with their thinking that 
it is appropriate to spend more money to reduce a high 
dose to a moderate dose than a moderate dose to a low 
dose. This fact notwithstanding, internationally there is 
a wide variation in the adopted value. An information 
system on occupational exposure review of values in 
2012 demonstrated this wide variation, reporting values 
from 13 to 3170k Euros per man-Sievert.33 There is some 
consensus on a value of 50k Euros.34
The use of the man-Sievert for patients under-
going X-ray examinations is more controversial. The 
data used for risk models is mostly from occupational 
or public exposure that was of no benefit to the indi-
vidual. X-ray examinations are justified which is a 
process that includes weighing the benefits against the 
risks, which include the radiation exposure. In 1986, the 
(then) National Radiological Protection Board (NRPB) 
recommended values for the man-Sievert.35 These were 
set at 50k Pounds per man-Sievert for occupational 
exposures and medical exposures of the general popu-
lation, 100k Pounds per man-Sievert for medical expo-
sures of the paediatric population and 10k Pounds 
per man-Sievert for medical exposures of the geriatric 
population. Whilst these proportional values match the 
risk profile for these populations, the differences are of 
limited practical use outside of specialist facilities since 
the same equipment is used on all patients. This demon-
strates one of the drawbacks of using the man-Sievert 
model in diagnostic radiology. Another is public percep-
tion, as noted by the authors of the Institute of Physics 
and Engineering in Medicine’s report 8236 in that the 
nuclear industry have higher values for man-Sievert 
owing to public pressure, whereas the values are lower 
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conclusions
The use of a thyroid shield for anterior oblique occlusal 
intraoral examinations has been evaluated with respect 
to the reduction in thyroid and effective dose. There is 
a dose reduction to the thyroid of around 36% with an 
associated decrease in effective dose of 22%. In abso-
lute terms, however, these reductions are small enough 
that the purchase of a thyroid shield for this purpose 
is unlikely to be a cost-effective means of optimization 
unless the department or surgery performs a very high 
number of anterior oblique occlusal views. Those who 
do choose to use a thyroid shield must consider the 
provision and cost of appropriate storage, a thorough 
cleaning regimen and arranging periodic fluoroscopy 
testing. It has been demonstrated that suboptimal posi-
tioning for this examination can significantly increase 
the dose to the thyroid. Optimization efforts for this 
examination are likely to be better focussed on training 
and audit of examination positioning for all operators.
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